Status:
COMPLETED
Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
antimüllerian Hormone and Gonadotrophin Receptor Polymorphism as Predictors of Ovarian Response
Eligibility:
FEMALE
18-45 years
Brief Summary
Aim of study: To compare the relationship between serum AMH and ovarian response for IVF with the GnRH antagonist protocol in patients who are carriers of FSH and/or LH receptor polymorphisms with tho...
Detailed Description
Serum AMH has shown to have a high predictive capability of the ovarian response to stimulation for IVF. On the other hand, patients who are carriers of polymorphisms in the FSH and LH receptors, have...
Eligibility Criteria
Inclusion
- 18-45 years of age presenting to IVF clinic
- BMI of 18-35 kg/m2
- Having been tested for serum AMH with the Elecsys assay
- Being planned to undergo ovarian stimulation cycle for IVF with the GnRH antagonist protocol
- Signed written informed consent or waiver
Exclusion
- Current or past disease affecting ovaries, gonadotropin or sex steroid
- Current hormone therapy
Key Trial Info
Start Date :
January 11 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2019
Estimated Enrollment :
296 Patients enrolled
Trial Details
Trial ID
NCT03388099
Start Date
January 11 2018
End Date
December 18 2019
Last Update
December 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Valencian Institute of Infertility, IVI RMA. Valencia
Valencia, Spain, 46015